TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
RCKT

Rocket Pharmaceuticals Inc

Healthcare · Biotechnology

2.70$ -10.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RCKT
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– – 0.00 0.01 0.03 0.03 0.01 0.01 0.02 0.08 0.09 0.08 0.10 0.10
– – 0.00 -0.01 -0.03 -0.03 -0.01 -0.01 -0.02 -0.08 -0.09 -0.08 -0.10 -0.10
1.68 2.53 2.66 1.90 4.79 2.10 1.35 1.20 1.92 1.98 2.43 2.22 1.81 1.28
1.10 0.63 1.00 1.19 1.48 1.85 0.45 0.36 0.50 0.66 0.86 0.87 1.08 0.78
2.78 3.16 3.66 3.09 6.27 3.95 1.80 1.55 2.44 2.64 3.29 3.09 2.88 1.96
-2.78 -3.16 -3.66 -3.09 -6.27 -3.95 -1.81 -1.55 -2.46 -2.64 -3.29 -3.09 -2.88 -2.06
0.10 0.42 0.47 0.19 0.21 0.53 0.13 0.10 0.14 0.09 0.03 0.02 0.02 0.02
-2.88 -3.62 -4.53 -10.29 -6.41 -4.36 -1.89 -1.58 -2.52 -2.67 -3.26 -2.92 -2.73 -2.01
0.10 0.42 0.00 0.19 0.07 0.12 0.07 0.12 0.13 0.01 -0.04 -2.92 0.00 –
-2.88 -3.62 -4.53 -10.29 -6.41 -4.36 -1.89 -1.70 -2.65 -2.67 -3.26 -2.92 -2.73 -2.01
-2.77 -3.20 -3.66 -3.07 -6.17 -3.95 -1.81 -1.45 -2.38 -2.50 -3.14 -2.82 -2.61 -1.89

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?